Connor, Clark & Lunn Investment Management Ltd. Glaukos Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 46,913 shares of GKOS stock, worth $6.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

46,913

Previous 89,711 47.71%

Holding current value

$6.96 Million

Previous $10.6 Million 42.44%

% of portfolio

0.03%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$113.62 - $135.39 $4.86 Million - $5.79 Million	-42,798 Reduced 47.71%	46,913 $6.11 Million
Q2 2024 Aug 09, 2024	SELL	$89.48 - $118.35 $1 Million - $1.33 Million	-11,225 Reduced 11.12%	89,711 $10.6 Million
Q1 2024 May 09, 2024	BUY	$76.4 - $96.33 $239,666 - $302,187	3,137 Added 3.21%	100,936 $9.52 Million
Q4 2023 Feb 09, 2024	BUY	$59.53 - $85.11 $1.31 Million - $1.87 Million	22,018 Added 29.05%	97,799 $7.77 Million
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $2.36 Million - $2.7 Million	-34,157 Reduced 31.07%	75,781 $5.7 Million
Q2 2023 Aug 10, 2023	BUY	$45.44 - $71.21 $2.36 Million - $3.69 Million	51,872 Added 89.33%	109,938 $7.83 Million
Q1 2023 May 09, 2023	BUY	$43.88 - $52.48 $618,795 - $740,072	14,102 Added 32.08%	58,066 $2.91 Million
Q4 2022 Feb 10, 2023	BUY	$40.82 - $57.75 $913,592 - $1.29 Million	22,381 Added 103.7%	43,964 $1.92 Million
Q3 2022 Nov 10, 2022	BUY	$46.84 - $58.49 $207,126 - $258,642	4,422 Added 25.77%	21,583 $1.15 Million
Q2 2022 Aug 05, 2022	SELL	$34.86 - $63.77 $395,695 - $723,853	-11,351 Reduced 39.81%	17,161 $779,000
Q1 2022 May 12, 2022	SELL	$44.33 - $57.82 $1.22 Million - $1.59 Million	-27,534 Reduced 49.13%	28,512 $1.65 Million
Q4 2021 Feb 10, 2022	SELL	$40.27 - $56.99 $1.12 Million - $1.59 Million	-27,894 Reduced 33.23%	56,046 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $1.94 Million - $3.44 Million	40,808 Added 94.61%	83,940 $4.04 Million
Q2 2021 Aug 12, 2021	BUY	$73.06 - $97.7 $1.75 Million - $2.34 Million	23,964 Added 125.02%	43,132 $3.66 Million
Q1 2021 May 13, 2021	BUY	$70.43 - $97.42 $1.35 Million - $1.87 Million	19,168 New	19,168 $1.61 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.06B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Glaukos Corp Transaction History